Publication | Closed Access

Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38)

Contrast AgentsEngineeringMedical ImagingBiomedical ImagingBreast ImagingFunctional Ultrasound ImagingBreast CancerBiomedical EngineeringContrast AgentUltrasoundMolecular ImagingRadiologyHealth Sciences